Robert Pearce

Robert Pearce
T: +44 (0) 20 7246 0517

Robert is Director, Head of Research at Catalyst.

As well as leading our research function, Robert is responsible for researching and assessing trade acquirers and identifying acquisition targets for financial and corporate buyers. In addition, Robert works closely with our international partner firms on buy and sell side opportunities.

He has a particular focus on trends within the consumer and waste & clean technology sectors and is instrumental in the production of the CIWM & Catalyst Waste Fast 50 and the Grocer Fast 50.


During his Accounting and Finance degree at Nottingham Business School, Robert undertook a placement year at Catalyst working as a junior analyst within the research department. On graduation, he spent a year working within his family business before moving to join the Catalyst research team full time in 2007.

Robert has supported the delivery of a number of transactions including the £163m acquisition of Concept Life Sciences by Spectris plc; the management buy-out of YSC (2017), five acquisitions for Spain's SAICA, the most recent being the acquisition of Americk Packaging; the sales of CP Electronics and Texon; working with the shareholders of Powwownow on its sale to US-based PGi; and supporting Daelmans on the identification and acquisition of Fabulous Bakin’ Boys.

Outside of work Robert enjoys a host of country pursuits and is a keen competitive cyclist.

Catalyst advises Spectris plc on its acquisition of Concept Life Sciences

Catalyst Corporate Finance has advised Spectris plc, the productivity-enhancing instrumentation and controls company, on its acquisition of Concept Life Sciences.  

Advisor to WernerCo and Triton Partners on the acquisition of Zarges Group

We advised WernerCo and Triton Partners on the acquisition of Zarges Group, a leading provider of professional access, storage and special construction solutions. 

Catalyst advises Piper on investment in Neom Organics

Catalyst has advised Piper on its investment in beauty and wellbeing brand Neom Organics (“Neom”). 

Catalyst advises Synova on 4Ways Healthcare refinancing

We advised Synova Capital on its refinancing of portfolio company 4Ways Healthcare, a leading provider of tele-diagnostic services to the healthcare sector.  

Catalyst advises PCMS Group on its sale to a management buy-out team backed by Inflexion Private Equity

Catalyst has advised PCMS Group, a leading provider of point-of-sale software and services for major retailers, on its sale to a management buy-out team, backed by Inflexion.